Get started
SPDR Series Trust SPDR S&P Biotech ETFSPDR Series Trust SPDR S&P Biotech ETFSPDR Series Trust SPDR S&P Biotech ETF

SPDR Series Trust SPDR S&P Biotech ETF

No trades
See on Supercharts
Overview Analysis Holdings News
Ideas
Discussions Technicals Seasonals Options

XBI trade ideas

Biotech etf year in review: O$92.76 H$152.70 L$62.94 C <=> $144Biotech etf year in review: O $92.76 H $152.70 L $62.94 C <=> $144 Do your own due diligence, your risk is 100% your responsibility. You win some or you learn some. Consider being charitable with some of your profit to help humankind. Small incremental steps work : If you double a penny a day for a month it = $5,368,709. Good luck and happy trading friends... *3x lucky 7s of trading* 7pt Trading compass: Price action, entry/exit Volume average/direction Trend, patterns, momentum Newsworthy current events Revenue Earnings Balance sheet 7 Common mistakes: +5% portfolio trades, risk management Beware of analysts motives Emotions & Opinions FOMO : bad timing Lack of planning & discipline Forgetting restraint Obdurate repetitive errors, no adaptation 7 Important tools: Trading View app!, Brokerage UI Accurate indicators & settings Wide screen monitor/s Trading log (pencil & graph paper) Big organized desk Reading books, playing chess Sorted watch-list Checkout my indicators: Fibonacci VIP - volume Fibonacci MA7 - price pi RSI - trend momentum TTC - trend channel www.tradingview.com
AMEX:XBI
by Options360
OPENING (IRA): XBI NOV/DEC/JAN 87/90/93 SHORT PUT LADDER... for a 5.91 credit in total. Notes: Going where the volatility is ... . 30-day greater than 35% (39.8%) with the November at-the-money short straddle paying 13.1% of where the stock is currently trading. This isn't usually an IRA play I go for, since you won't get paid to wait if you get assigned shares (the yield is absolutely paltry at .10%). However, I'm pretty much in all the plays or in a closely correlated play at the top of the exchange-traded-fund board: XOP (56.2%) (play on in XLE); GDXJ (51.1%) (plays on in SLV and GLD); SLV (47.7%); EWZ (47.5%); GDX (42.9%) (plays on in SLV/GLD); XLE (42.6%), and SMH (39.6%) (no play on).
AMEX:XBI
by NaughtyPines
Equities - Own What is Working! Pt. 3Please check out my blog post for the full details: www.derzzycharts.com Now we may be seeing a double RSI divergence coming up here, which is where we exit another third of our position. Very key to also think on the bullish side here and consider that the RSI could hit new highs, which discounts the bearish divergence. Very key to watch at these levels because we are either adding capital on the pullback or locking in gains if the double bearish divergence is confirmed. What about QQQ? Equities - Own What is Working! Pt. 4 Happy Trading! Brandon Anderson brandon@derzzycharts.com @derzzycharts www.derzzycharts.com
AMEX:XBI
by derzzycharts
Biotech Channel 7/18/2020I've noticed that most tech related ETFs and the NQ are in the same general channel. This is the XBI at the 4 hour view. It's the biotech ETF. As you may see, my buy zone is way below. This may be due to the coronavirus vaccine hype. Not sure. Either way, biotech has been grinding at the top of my channel for a while. If it pops above it, it will likely get hammered down. I'll short it if it pops above my channel and go long when it gets hammered down to my buy zone.
AMEX:XBI
by Itsallsotiresome
2
Quick Flag Break to ResistanceNeed to see short term continuation above the recent 114 resistance, S/R flip possibly, to remain bullish. Strong move up from recent flag after flag pattern, but the quick stall out causes concern for weakness. If it fails to overtake the 114 level, then likely pullback to the volume shelf around 104 which could coincide with a MACD bearish crossover and possibly result in a relatively large bearish divergence. Short term - Neutral until immediate move up above 114 to long the continuation towards the bottom of the previous channel (blue)
AMEX:XBI
by ItsBones
XBI - On the verge of ANOTHER historic 300% run?First 5 years were quite disappointing for XBI, as it was locked in a big "penalty box" from the spring of '06 to the spring of 2011... BUT is was slowly building a BIG ascending triangle, fraught with false breakouts (blue arrow), and FINALLY, a break-and-retest of the all time highs (green arrow). From this ATH (upper boundary of the box), to the blow-off top in July 2015, the NET gain was almost 300% over 4 years, on an UNLEVERAGED, DIVERSIFIED ETF!!! How cool would it be if history repeated itself? XBI found itself again inside of a big nasty "penalty box" over the last 5/6 years, BUT it managed to form a BIG ascending triangle, fraught with false breakouts (blue arrows), and FINALLY, a break-and-retest of all time highs (green arrow). Will it quadruple over the next years just like last time? In 2011, rates had been cut aggressively and the world was coming out of a backbreaking recession... Sounds familiar? Just beware of externalities that may rock the boat!! In Agust 2011, the US debt downgrade and the European debt crisis plunged equities into a hole, but for biotech, it was only one last scary shakeout (red arrow) before a historic run! Full disclosure: I own several biotech stocks totaling over 20% of total assets, and am actively seeking to increase my exposure to this sector. While I don't own XBI, I have reccomended it and similar funds to people unable or unwilling to buy individual stocks. Only buy the amount of stock that you can be sure to hold in the worst market conditions. The bigger the potential upside, the bigger the risk of temporary drawdowns. And they come when you LEAST expect them. Just look at June-August 2011... Buy on pullbacks, NEVER chase prices.
AMEX:XBILong
by dogchasingcogChasingCars
2
Sector Rotation Strangle - Long Bio, Short Specialty RetailThis is a complex play that involves a lot of risk and the use of options on both ETFs and Stocks. Goal: Capture the apparent sector rotation activity between Biotechnology and Specialty Retail. I have been waiting quite some time for these two sectors to start playing out the way they ought to, based on earnings across the board and common sense. I see LULU's miss as the final act before the fringe players in the retail space get hammered down. I have also been waiting for biotech to turn, as it has been stagnant for quite some time. I think getting into VRTX is wise, as it is one of the top players in the space and just got a nice price upgrade. Meanwhile, while longing VRTX and XBI (bio ETF), I plan on buying a put position in URBN (worst specialty retailer) and XRT (specialty retail ETF. Again, very risky play given the current market environment, but the tape tells me this will work. Let's see. AMEX:XBI AMEX:XRT NASDAQ:VRTX NASDAQ:URBN
AMEX:XBI
by UnknownUnicorn5511258
2
Biotech - 3rd Time is a charm?What I see... + Long hammer that closed above 10ma + 50ma has just crossed above the 200ma + Prices have just broke above the neckline of a head and shoulder pattern + RSI is flat at 59.2 + MACD is below the signal line but in bullish territory + 10ma continues to play Support role - Bearish engulf on -1d bar - Today's vol. is lesser than -1d What I setup... + Long entry above today's high - Stop under today's low + Target at 1.613 fib :: Duration - 2 to 3 weeks * Comments and Likes are appreciated; Subscribers are oil rich! *
AMEX:XBILong
by ShakeShakeLeg
2